Valiant Organics Limited AI Stock Analysis
Want to see IN:VALIANTORG full AI Analyst Report?
Valiant Organics Limited (VALIANTORG) AI Stock Analysis
Valiant Organics Limited
(NSE:VALIANTORG)
The overall score reflects a company with improving fundamentals but weak market sentiment. The primary strength is a solid financial recovery, marked by robust cash flow and a strong balance sheet. This is significantly offset by poor technical momentum, as the stock price is in a downtrend with bearish indicators. The moderate valuation provides little catalyst either way.
Valiant Organics Limited (VALIANTORG) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 9.70B
- Dividend Yield
- ―
- Average Volume (3M)
- 8,537
- Price to Earnings (P/E)
- 14.8
- Beta (1Y)
- 0.23
- Revenue Growth
- 21.32%
- EPS Growth
- 175.87%
- Country
- India
- Employees
- 908
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Valiant Organics Limited Business Overview & Revenue Model
Company Description
Founded in Mumbai, India, in 1984, Valiant Organics Limited operates as a chemical manufacturer, specializing in the production and distribution of specialty chemicals across India. Their diverse product portfolio encompasses a variety of chloropheno...
Valiant Organics Limited Financial Statement Overview
Summary
Financial recovery is evident with positive net income and strong cash flow growth, supported by a healthy, low-leverage balance sheet. However, the score is tempered by declining revenue and margins that remain below historical peaks.
Income Statement
58NeutralBalance Sheet
78PositiveCash Flow
72Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.14B | 7.39B | 7.19B | 7.23B | 10.52B | 11.53B |
| Gross Profit | 2.90B | 2.13B | 2.62B | 470.01M | 1.81B | 2.17B |
| EBITDA | 1.24B | 996.99M | 615.51M | 425.75M | 1.77B | 2.12B |
| Net Income | 657.14M | 332.36M | -37.36M | -83.91M | 881.21M | 1.13B |
Balance Sheet | ||||||
| Total Assets | 13.35B | 12.31B | 11.83B | 12.48B | 12.39B | 11.92B |
| Cash, Cash Equivalents and Short-Term Investments | 68.64M | 21.24M | 131.53M | 71.02M | 456.71M | 499.47M |
| Total Debt | 2.59B | 2.56B | 2.49B | 2.57B | 2.74B | 3.63B |
| Total Liabilities | 5.29B | 4.71B | 4.58B | 5.19B | 4.99B | 5.43B |
| Stockholders Equity | 8.06B | 7.59B | 7.25B | 7.29B | 6.89B | 6.13B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 439.27M | 256.03M | 90.70M | 862.19M | -1.53B |
| Operating Cash Flow | 0 | 774.59M | 564.32M | 840.00M | 2.38B | -307.47M |
| Investing Cash Flow | 0 | -898.89M | -209.61M | -649.88M | -1.43B | -1.24B |
| Financing Cash Flow | 0 | 71.27M | -318.13M | -231.19M | -1.12B | 1.67B |
Valiant Organics Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Negative. The current price of 348.55 is below the 20-day moving average (MA) of 402.86, below the 50-day MA of 412.05, and above the 200-day MA of 305.60, indicating a neutral trend. The MACD of -20.02 indicates Positive momentum. The RSI at 38.40 is Neutral, neither overbought nor oversold. The STOCH value of 12.32 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VALIANTORG.
Valiant Organics Limited Peers Comparison
Overall Rating
IN:INDIAGLYCO80Outperform
IN:INDOAMIN76Outperform
IN:DEEPAKNTR65Neutral
IN:VALIANTORG58Neutral
IN:PUNJABCHEM55Neutral
IN:NAVINFLUOR50Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | INR 18.46B | 5.57 | ― | 0.94% | 12.01% | 23.71% | |
| 76Outperform | INR 8.29B | 10.27 | ― | 0.44% | 13.23% | 22.22% | |
| 65Neutral | INR 216.86B | 20.41 | ― | 0.47% | 25.13% | 99.89% | |
| 58Neutral | INR 9.77B | 14.85 | ― | ― | 21.32% | 175.87% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 11.02B | 18.18 | ― | 0.33% | 13.95% | 15.36% | |
| 50Neutral | INR 504.83B | 55.26 | ― | 0.17% | 45.68% | 100.24% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:VALIANTORG | Valiant Organics Limited | 348.55 | 68.50 | 24.46% | |
| IN:DEEPAKNTR | Deepak Nitrite Limited | 1590.00 | -115.21 | -6.76% | |
| IN:INDIAGLYCO | India Glycols Limited | 275.35 | 45.33 | 19.71% | |
| IN:INDOAMIN | Indo Amines Limited | 114.15 | -13.68 | -10.70% | |
| IN:NAVINFLUOR | Navin Fluorine International Limited | 9839.00 | 3831.63 | 63.78% | |
| IN:PUNJABCHEM | Punjab Chemicals & Crop Protection Ltd. | 898.50 | -451.71 | -33.45% |
Valiant Organics Limited Corporate Events
Valiant Organics posts Q1 FY27 results, renews MD and shifts registered office
Valiant Organics Limited’s board has approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following audit committee review, and will publish these figures in accordance with securities regulations. The...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026
